ArticleCancer immunology, immunotherapy : CII2025

BAP1 as a predictive biomarker of therapeutic response to oncolytic vaccinia virus for metastatic renal cell carcinoma therapy.

Jee Soo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.